These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20680986)

  • 1. Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patients.
    Noubary F; Hughes MD
    Stat Med; 2010 Aug; 29(18):1932-46. PubMed ID: 20680986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute lymphocyte count as a marker for CD4 T-lymphocyte count: criterion for initiating antiretroviral therapy in HIV infected Nigerians.
    Erhabor O; Uko EK; Adias T
    Niger J Med; 2006; 15(1):56-9. PubMed ID: 16649453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.
    Daneau G; Buyze J; Wade D; Diaw PA; Dieye TN; Sopheak T; Florence E; Lynen L; Kestens L
    Cytometry B Clin Cytom; 2017 Nov; 92(6):476-484. PubMed ID: 26917223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries.
    Balakrishnan P; Dunne M; Kumarasamy N; Crowe S; Subbulakshmi G; Ganesh AK; Cecelia AJ; Roth P; Mayer KH; Thyagarajan SP; Solomon S
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1006-10. PubMed ID: 15247552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 counting technologies for HIV therapy monitoring in resource-poor settings--state-of-the-art and emerging microtechnologies.
    Glynn MT; Kinahan DJ; Ducrée J
    Lab Chip; 2013 Jul; 13(14):2731-48. PubMed ID: 23670110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
    Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kazé S; Molinari N; Bourgeois A; Mpoudi-Ngolé E; Spire B; Koulla-Shiro S; Delaporte E;
    Lancet Infect Dis; 2011 Nov; 11(11):825-33. PubMed ID: 21831714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis.
    Bendavid E; Young SD; Katzenstein DA; Bayoumi AM; Sanders GD; Owens DK
    Arch Intern Med; 2008 Sep; 168(17):1910-8. PubMed ID: 18809819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patients.
    Stirrup OT; Babiker AG; Copas AJ
    BMC Med Res Methodol; 2016 Sep; 16():121. PubMed ID: 27633882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CD4 counts and percentages in the HIV infected Indian population.
    Vajpayee M; Kanswal S; Wig N; Seth P
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):144-6. PubMed ID: 15272758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
    Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India.
    Ghate MV; Mehendale SM; Mahajan BA; Yadav R; Brahme RG; Divekar AD; Paranjape RS
    Natl Med J India; 2000; 13(4):183-7. PubMed ID: 11002684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
    ; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
    Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to start antiretroviral therapy in resource-limited settings.
    Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
    Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of blood sampling for CD4 T-cell counting influences HAART decisions.
    Bekele Y; Mengistu Y; de Wit TR; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):187-97. PubMed ID: 21991752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
    Sukapirom K; Onlamoon N; Thepthai C; Polsrila K; Tassaneetrithep B; Pattanapanyasat K
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):141-7. PubMed ID: 21709568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Daar ES; Simberkoff MS; Hamilton JD
    Ann Intern Med; 1997 Jun; 126(12):939-45. PubMed ID: 9182470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid manual method for CD4+ T-cell quantitation for use in developing countries.
    Landay A; Ho JL; Hom D; Russell T; Zwerner R; Minuty JG; Kataaha P; Mmiro F; Jackson B
    AIDS; 1993 Dec; 7(12):1565-8. PubMed ID: 7904449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.